[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
January 16, 2002

FDA Chastises Red Cross

Author Affiliations
 

Not Available

Not Available

JAMA. 2002;287(3):308. doi:10.1001/jama.287.3.308-JHA10014-3-1

The US Food and Drug Administration (FDA) has asked the US District Court for the District of Columbia for authority to impose fines on the American Red Cross for blood product safety violations. In December, the FDA released a statement saying that the Red Cross had failed to improve its safety record despite signing a 1993 court document promising to do so.

In early 2000, the FDA reported violations at Red Cross headquarters in Washington, including incorrect labeling and release of blood potentially contaminated with cytomegalovirus. The agency also cited inadequate quarantine and premature release of blood.

First Page Preview View Large
First page PDF preview
First page PDF preview
×